by Nicole Espinoza, Nov 20, 2019
One of the reasons that we built HealthPlanView was to redefine how account management and senior Market Access executives assess the value of the access and coverage that health plans are delivering. Most pharmaceutical manufacturers have a singular focus on Rx volume, delivered with little consideration of how that volume is derived. Rebates seldom consider the nuances of benefit designs and how patients seldom pay the copays that manufacturers contract for because of deductibles. The first... Read More
